Registered entities
AVSF - Surge Therapeutics 2023, LLC
Reg. No. 1982296United States
Investor mix
10 investors on record; lead investors include Bioluminescence Ventures, Camford Capital.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 5 | 50% |
| Bank & private debt | 2 | 20% |
| Other / undisclosed | 3 | 30% |
